Has medicinal cannabis found a role in oncology/palliative care?
Authors:
- 5 February 2025
- journal article
- Published by Wiley in Internal Medicine Journal
- Vol. 55 (2) , 183-185
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Does medicinal cannabis affect depression, anxiety, and stress in people with cancer? A systematic review and meta-analysis of intervention studiesMaturitas, 2024
- Cannabis use prevalence, patterns, and reasons for use among patients with cancer and survivors in a state without legal cannabis accessSupportive Care in Cancer, 2023
- Cannabis use among adults undergoing cancer treatmentCancer, 2023
- MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse eventsSupportive Care in Cancer, 2023
- Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depressionSupportive Care in Cancer, 2023
- Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancerSupportive Care in Cancer, 2022
- Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for PainJAMA Network Open, 2022
- Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studiesNeuropsychopharmacology, 2022
- A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastomaBritish Journal of Cancer, 2021
- Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trialAnnals of Oncology, 2020